<DOC>
	<DOCNO>NCT02149992</DOCNO>
	<brief_summary>Myo-inositol show decrease rate diabetes pregnancy European study . It know exactly occur sugar supplement take . This study purpose look patient 's sugar level take supplement see overall level sugar go . We hypothesize addition sugar level , hormone influence diabetes alter .</brief_summary>
	<brief_title>Glycemic Impact Myo-inositol Pregnancy</brief_title>
	<detailed_description>Myo-inositol important glucose homeostasis show improve insulin sensitivity . This prospective cohort pilot study determine daily glycemic pharmacokinetics metabolic influence myo-inositol supplementation use continuous glucose monitoring system ( CGMS ) pre- post-supplement blood work high risk pregnancy woman diagnose gestational diabetes mellitis ( GDM ) . Risk factor include : obesity , previous pregnancy GDM , family history diabetes , glucose intolerance , polycystic ovarian syndrome ( PCOS ) . Women CGMS device place day one begin 3 day placebo plus folic acid ( 400mcg ) determine baseline glycemia metabolic level . For final 4 day , woman take myo-inositol supplementation ( 4g ) plus folic acid ( 400mcg ) . The CGMS device remove day 7 final blood work obtain . Self-capillary glucose test 4 time per day record calibrate CGMS glucose value . These observation help determine effect myo-inositol overall mean glucose metabolic factor high risk GDM patient , identify pharmacokinetic discipline pregnancy , develop groundwork future prospective clinical trial prevention and/or augmentation treatment GDM .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>Englishspeaking singleton pregnant female 2028 week gestation time enrollment PLUS ( either follow ) High risk include woman must pass routine glucose screen great equal 1 follow high risk criterion : first degree family member diabetes mellitus , previous pregnancy gestational diabetes , PCOS , body mass index great equal 30 . Gestational diabetes diagnose current pregnancy base IADPSG NIH consensus diagnostic recommendation prepregnancy diagnosis diabetes mellitus renal disease immunocompromised currently take immunosuppressive medication age &lt; 13 year old nonEnglish speaking multifetal gestation .</criteria>
	<gender>Female</gender>
	<minimum_age>13 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>gestational diabetes</keyword>
	<keyword>myoinositol</keyword>
</DOC>